Harmony Biosciences Holdings, Inc.

HRMY
As of the close on Sep 25, 2026
Price
$41.26
Market cap
$2.4B
P/E (diluted TTM)
13.4
EPS (TTM)
$3.08
Four quarters to Jun 30, 2026
Dividend yield
—
Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Harmony Biosciences Holdings, Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Harmony Biosciences Holdings, Inc. — 10-Q filed Aug 4, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 7 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 18, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Reported 13F positions

Each row shows what a filer reported for one date, not a current position. The link opens that filing.

Filer Report date Shares Value Filing
Advyzon Investment Management, LLC 2026-03-31 19,129 $536K SEC filing
GHP Investment Advisors, Inc. 2026-03-31 2 $57 SEC filing
FRANKLIN RESOURCES INC 2026-03-31 188,140 $5.27M SEC filing
Nuveen, LLC 2026-03-31 80,975 $2.27M SEC filing
Creative Planning 2026-03-31 27,305 $765K SEC filing
BLAIR WILLIAM & CO/IL 2026-03-31 14,389 $403K SEC filing
True Wealth Design, LLC 2026-03-31 118 $3.31K SEC filing
Police & Firemen's Retirement System of New Jersey 2026-03-31 12,117 $339K SEC filing
Callan Family Office, LLC 2026-03-31 15,584 $437K SEC filing
LOS ANGELES CAPITAL MANAGEMENT LLC 2026-03-31 166,198 $4.66M SEC filing
Root Financial Partners, LLC 2026-03-31 3 $84 SEC filing
Hennion & Walsh Asset Management, Inc. 2026-03-31 92,354 $2.59M SEC filing
QUADRANT CAPITAL GROUP LLC 2026-03-31 394 $11K SEC filing
SJS Investment Consulting Inc. 2026-03-31 42 $1.18K SEC filing
STRS OHIO 2026-03-31 20,800 $583K SEC filing
Hedeker Wealth, LLC 2026-03-31 60,865 $1.7M SEC filing
JONES FINANCIAL COMPANIES LLLP 2026-03-31 291 $7.72K SEC filing
Squarepoint Ops LLC 2026-03-31 41,100 $1.15M SEC filing
IEQ CAPITAL, LLC 2026-03-31 37,898 $1.06M SEC filing
CREATIVE FINANCIAL DESIGNS INC /ADV 2026-03-31 4 $112 SEC filing

120 filers have only one report here.

Unusually large insider trades

Each trade is compared with the other insider trades of the same kind in the same security among Harmony Biosciences Holdings, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.

  • 2024-11-05 · Gracias Antonio J.: Larger than 63 of the 66 other insider sales of Common Stock on file. SEC filing
  • 2024-11-05 · Marshman Fund Trust II: Larger than 63 of the 66 other insider sales of Common Stock on file. SEC filing
  • 2024-11-01 · Gracias Antonio J.: Larger than 65 of the 66 other insider sales of Common Stock on file. SEC filing
  • 2024-11-01 · Marshman Fund Trust II: Larger than 65 of the 66 other insider sales of Common Stock on file. SEC filing
  • 2022-11-04 · Wicki Andreas: Larger than 60 of the 66 other insider sales of Common Stock on file. SEC filing
  • 2022-11-03 · Wicki Andreas: Larger than 62 of the 66 other insider sales of Common Stock on file. SEC filing
  • 2022-11-02 · Wicki Andreas: Larger than 61 of the 66 other insider sales of Common Stock on file. SEC filing

Purchases & sales (open market or private)

SecurityCodePriceFiling
2026-01-26Kapadia Sandip · CHIEF FINANCIAL OFFICERCommon StockS — Open market or private sale−3,74637.15SEC filing
2026-01-15Kapadia Sandip · CHIEF FINANCIAL OFFICERCommon StockS — Open market or private sale−20,96135.92SEC filing
2025-12-12Dayno Jeffrey M. · PRESIDENT, CEOCommon StockS — Open market or private sale−20,00040.11SEC filing
2025-12-12Dayno Jeffrey M. · PRESIDENT, CEOCommon StockS — Open market or private sale−5,93340.11SEC filing
2025-12-05Kapadia Sandip · CHIEF FINANCIAL OFFICERCommon StockS — Open market or private sale−20,00039.54SEC filing
2025-11-21Kapadia Sandip · CHIEF FINANCIAL OFFICERCommon StockS — Open market or private sale−3,42735.00SEC filing
2025-08-15Kapadia Sandip · CHIEF FINANCIAL OFFICERCommon StockS — Open market or private sale−21,57336.50SEC filing
2025-04-01Kapadia Sandip · CHIEF FINANCIAL OFFICERCommon StockS — Open market or private sale−74033.12SEC filing

Showing 8 of 10 rows

Grants, exercises, tax & gifts

SecurityCodeFiling
2026-05-14Sabater Juan A. · DirectorStock OptionA — Grant, award, or other acquisition+21,872SEC filing
2026-05-14Graf R. Mark · DirectorStock OptionA — Grant, award, or other acquisition+21,872SEC filing
2026-05-14Germano Geno J · DirectorStock OptionA — Grant, award, or other acquisition+21,231SEC filing
2026-05-14Sender Gary · DirectorStock OptionA — Grant, award, or other acquisition+21,872SEC filing
2026-05-14Philip Ron M · DirectorStock OptionA — Grant, award, or other acquisition+21,872SEC filing
2026-05-14Szyper Linda M · DirectorStock OptionA — Grant, award, or other acquisition+21,872SEC filing
2026-05-01Budur Kumar · CHIEF MEDICAL OFFICERRestricted Stock UnitsM — Exercise or conversion of derivative security−18,750SEC filing
2026-05-01Budur Kumar · CHIEF MEDICAL OFFICERCommon StockM — Exercise or conversion of derivative security+18,750SEC filing

Showing 8 of 30 rows

Other activity

SecurityCodeFiling
2025-08-28Gracias Antonio J. · Director, 10% ownerCommon StockJ — Other acquisition or disposition−6,618,033SEC filing

Showing 1 of 1 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.